the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Indonesia open: Zii Jia sets up quarter-final clash with Kunlavut

KUALA LUMPUR: Malaysia’s professional badminton player Lee Zii Jia stormed into the quarter-finals of the Indonesia Open 2024 after overcoming a strong challenge from China’s Weng Hong Yang tonight.

In the second-round clash at the iconic Istora Senayan, the world number seven Zii Jia found the going tough in the opening game and lost 20-22.

However, Zii Jia came back strongly to beat the world number 19 Hong Yang 21-9 and 21-16 in the next two games to book his quarter-final slot.

Tomorrow, Zii Jia will meet 2023 world champion Kunlavut Vitidsarn of Thailand, who advanced to the last eight after disposing of India’s Priyanshu Rajawat 21-10, 21-17.

Zii Jia last played Kunlavut in the men’s singles third round of the 2022 Hangzhou Asian Games last year, with the 26-year-old Malaysian winning 10-21, 21-19, 21-6.

National women’s doubles pair Pearly Tan-M. Thinaah also qualified for the last eight after defeating Indonesia’s Apriyani Rahayu-Siti Fadia Silva Ramadhanti 21-18, 21-19. They will next meet world number one Chen Qing Chen-Jia Yi Fan of China.

The national professional mixed doubles pair of Tan Kian Meng-Lai Pei Jing also advanced to the last eight after ousting Denmark’s Mathias Christiansen-Alexandra Boje 15-21, 23-21, 21-14.

The world number 21 pair will meet eighth seeds Kim Won Ho-Jeong Na Eun of South Korea tomorrow.

Earlier in the day, three Malaysian representatives also entered the quarter-finals, namely men’s singles player Leong Jun Hao and men’s doubles pairs Man Wei Chong-Tee Kai Wun and Goh Sze Fei-Nur Izzuddin Rumsani.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings